Profil
Gyu-Chang Yu currently works at KOREA PETROCHEMICAL IND Co., Ltd., as Independent Director from 2021 and Hanyang University, as Professor from 2006.
Dr. Yu also formerly worked at GI Innovation, Inc., as Independent Director from 2022 to 2024.
Dr. Yu received his doctorate degree in 1996 from the University of Wisconsin, undergraduate degree in 1991 from the University of Toledo (Ohio), and undergraduate degree from Chung-Ang University.
Postes actifs de Kyu-Chang Yoo
| Sociétés | Poste | Début |
|---|---|---|
| KOREA PETROCHEMICAL IND. CO., LTD. | Directeur/Membre du Conseil | 19/03/2021 |
Hanyang University
Hanyang University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2006 |
Anciens postes connus de Kyu-Chang Yoo
| Sociétés | Poste | Fin |
|---|---|---|
| GI INNOVATION, INC. | Directeur/Membre du Conseil | 29/03/2024 |
Formation de Kyu-Chang Yoo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toledo (Ohio)
University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KOREA PETROCHEMICAL IND Co., Ltd.
KOREA PETROCHEMICAL IND Co., Ltd. Chemicals: SpecialtyProcess Industries Manufactures monomers, polymers and industrial gases | Process Industries |
Hanyang University
Hanyang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chung-Ang University
Chung-Ang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GI Innovation, Inc.
GI Innovation, Inc. BiotechnologyHealth Technology Engages in research and development of immunotherapy drugs based on fusion proteins | Health Technology |
















